img

Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

The Dipeptidyl Peptidase IV (DPP-IV) inhibitors market refers to the industry that focuses on the production and distribution of medications known as DPP-IV inhibitors. DPP-IV inhibitors are a class of oral antidiabetic drugs used in the treatment of type 2 diabetes mellitus. They work by inhibiting the action of the enzyme DPP-IV, which leads to increased levels of incretin hormones and improved glycemic control.

Dipeptidyl Peptidase IV (DPP-IV) Inhibitors report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors market is projected to reach US$ 18170 million in 2029, increasing from US$ 11200 million in 2022, with the CAGR of 7.1% during the period of 2024 to 2029. Demand from Hospital Pharmacies and Retail Pharmacies are the major drivers for the industry.
The DPP-IV inhibitors market is a segment within the broader pharmaceutical industry, specifically in the field of diabetes management. It involves the development, manufacturing, and distribution of DPP-IV inhibitor medications used to treat type 2 diabetes.
The DPP-IV inhibitors market is influenced by factors such as the increasing prevalence of type 2 diabetes worldwide, the rising demand for effective oral antidiabetic medications, and the growing emphasis on diabetes management and control. Additionally, factors such as an aging population, sedentary lifestyles, and changes in dietary habits contribute to the market's growth.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


AstraZeneca
Boehringer
Eli Lilly
Merck
Mitsubishi Tanabe Pharma
Novartis
Takeda
Segment by Type
Sitagliptin
Vildagliptin
Saxagliptin
Linagliptin
Others

Segment by Application


Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Dipeptidyl Peptidase IV (DPP-IV) Inhibitors market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Dipeptidyl Peptidase IV (DPP-IV) Inhibitors industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Dipeptidyl Peptidase IV (DPP-IV) Inhibitors introduction, etc. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Overview
1.1 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Overview
1.2 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Segment by Type
1.2.1 Sitagliptin
1.2.2 Vildagliptin
1.2.3 Saxagliptin
1.2.4 Linagliptin
1.2.5 Others
1.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Type
1.3.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size Overview by Type (2018-2029)
1.3.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Historic Market Size Review by Type (2018-2024)
1.3.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Breakdown by Type (2018-2024)
1.4.2 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Breakdown by Type (2018-2024)
2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Competition by Company
2.1 Global Top Players by Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (2018-2024)
2.2 Global Top Players by Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (2018-2024)
2.3 Global Top Players by Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price (2018-2024)
2.4 Global Top Manufacturers Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Manufacturing Base Distribution, Sales Area, Product Type
2.5 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Competitive Situation and Trends
2.5.1 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dipeptidyl Peptidase IV (DPP-IV) Inhibitors as of 2022)
2.7 Date of Key Manufacturers Enter into Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market
2.8 Key Manufacturers Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Status and Outlook by Region
3.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Historic Market Size by Region
3.2.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume by Region (2018-2024)
3.2.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value by Region (2018-2024)
3.2.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Forecasted Market Size by Region
3.3.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume by Region (2024-2029)
3.3.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value by Region (2024-2029)
3.3.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors by Application
4.1 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Segment by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Application
4.2.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size Overview by Application (2018-2029)
4.2.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Historic Market Size Review by Application (2018-2024)
4.2.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Breakdown by Application (2018-2024)
4.3.2 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Breakdown by Application (2018-2024)
5 North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors by Country
5.1 North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Historic Market Size by Country
5.1.1 North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume by Country (2018-2024)
5.1.3 North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value by Country (2018-2024)
5.2 North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Forecasted Market Size by Country
5.2.1 North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume by Country (2024-2029)
5.2.2 North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value by Country (2024-2029)
6 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors by Country
6.1 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Historic Market Size by Country
6.1.1 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume by Country (2018-2024)
6.1.3 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value by Country (2018-2024)
6.2 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Forecasted Market Size by Country
6.2.1 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume by Country (2024-2029)
6.2.2 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value by Country (2024-2029)
7 Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors by Region
7.1 Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Historic Market Size by Region
7.1.1 Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Forecasted Market Size by Region
7.2.1 Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value by Region (2024-2029)
8 Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors by Country
8.1 Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Historic Market Size by Country
8.1.1 Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume by Country (2018-2024)
8.1.3 Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value by Country (2018-2024)
8.2 Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Forecasted Market Size by Country
8.2.1 Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume by Country (2024-2029)
8.2.2 Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value by Country (2024-2029)
9 Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors by Country
9.1 Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Historic Market Size by Country
9.1.1 Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Forecasted Market Size by Country
9.2.1 Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 AstraZeneca
10.1.1 AstraZeneca Company Information
10.1.2 AstraZeneca Introduction and Business Overview
10.1.3 AstraZeneca Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.1.4 AstraZeneca Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Products Offered
10.1.5 AstraZeneca Recent Development
10.2 Boehringer
10.2.1 Boehringer Company Information
10.2.2 Boehringer Introduction and Business Overview
10.2.3 Boehringer Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Boehringer Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Products Offered
10.2.5 Boehringer Recent Development
10.3 Eli Lilly
10.3.1 Eli Lilly Company Information
10.3.2 Eli Lilly Introduction and Business Overview
10.3.3 Eli Lilly Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Eli Lilly Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Products Offered
10.3.5 Eli Lilly Recent Development
10.4 Merck
10.4.1 Merck Company Information
10.4.2 Merck Introduction and Business Overview
10.4.3 Merck Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Merck Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Products Offered
10.4.5 Merck Recent Development
10.5 Mitsubishi Tanabe Pharma
10.5.1 Mitsubishi Tanabe Pharma Company Information
10.5.2 Mitsubishi Tanabe Pharma Introduction and Business Overview
10.5.3 Mitsubishi Tanabe Pharma Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Mitsubishi Tanabe Pharma Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Products Offered
10.5.5 Mitsubishi Tanabe Pharma Recent Development
10.6 Novartis
10.6.1 Novartis Company Information
10.6.2 Novartis Introduction and Business Overview
10.6.3 Novartis Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Novartis Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Products Offered
10.6.5 Novartis Recent Development
10.7 Takeda
10.7.1 Takeda Company Information
10.7.2 Takeda Introduction and Business Overview
10.7.3 Takeda Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Takeda Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Products Offered
10.7.5 Takeda Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Industrial Chain Analysis
11.4 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Dynamics
11.4.1 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Industry Trends
11.4.2 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Drivers
11.4.3 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Challenges
11.4.4 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Distributors
12.3 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Sitagliptin
Table 2. Major Company of Vildagliptin
Table 3. Major Company of Saxagliptin
Table 4. Major Company of Linagliptin
Table 5. Major Company of Others
Table 6. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2018-2024) & (K MT)
Table 8. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Volume by Type (2018-2024)
Table 9. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2018-2024) & (US& Million)
Table 10. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Share in Value by Type (2018-2024)
Table 11. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Type (2018-2024) & (USD/MT)
Table 12. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2024-2029) & (K MT)
Table 13. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Volume by Type (2024-2029)
Table 14. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2024-2029) & (US$ Million)
Table 15. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Value by Type (2024-2029)
Table 16. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Type (2024-2029) & (USD/MT)
Table 17. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2018-2024) & (K MT)
Table 18. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 19. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT) by Type (2018-2024)
Table 20. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 21. Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT) by Type (2018-2024)
Table 22. Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 23. Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT) by Type (2018-2024)
Table 24. Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 25. Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT) by Type (2018-2024)
Table 26. Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 27. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Company (2018-2024) & (K MT)
Table 28. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Share by Company (2018-2024)
Table 29. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Company (2018-2024) & (US$ Million)
Table 30. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Share by Company (2018-2024)
Table 31. Global Market Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Company (2018-2024) & (USD/MT)
Table 32. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dipeptidyl Peptidase IV (DPP-IV) Inhibitors as of 2022)
Table 35. Date of Key Manufacturers Enter into Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market
Table 36. Key Manufacturers Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Region (2018-2024) & (K MT)
Table 40. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Volume by Region (2018-2024)
Table 41. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Region (2018-2024) & (US$ Million)
Table 42. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Value by Region (2018-2024)
Table 43. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 44. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Region (2024-2029) & (K MT)
Table 45. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Volume by Region (2024-2029)
Table 46. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Region (2024-2029) & (US$ Million)
Table 47. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Value by Region (2024-2029)
Table 48. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2024-2029)
Table 49. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 50. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2018-2024) & (K MT)
Table 51. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Volume by Application (2018-2024)
Table 52. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 53. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Value by Application (2018-2024)
Table 54. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Application (2018-2024) & (USD/MT)
Table 55. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2024-2029) & (K MT)
Table 56. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Volume by Application (2024-2029)
Table 57. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2024-2029) & (US$ Million)
Table 58. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Value by Application (2024-2029)
Table 59. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Application (2024-2029) & (USD/MT)
Table 60. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2018-2024) (K MT)
Table 61. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 62. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2018-2024) (K MT)
Table 63. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 64. Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2018-2024) (K MT)
Table 65. Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 66. Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2018-2024) (K MT)
Table 67. Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 68. Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2018-2024) (K MT)
Table 69. Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 70. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2018-2024) & (K MT)
Table 71. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Volume by Country (2018-2024)
Table 72. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2018-2024) & (US$ Million)
Table 73. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Value by Country (2018-2024)
Table 74. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2024-2029) & (K MT)
Table 75. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Volume by Country (2024-2029)
Table 76. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2024-2029) & (US$ Million)
Table 77. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Value by Country (2024-2029)
Table 78. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2018-2024) & (K MT)
Table 79. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Volume by Country (2018-2024)
Table 80. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2018-2024) & (US$ Million)
Table 81. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Value by Country (2018-2024)
Table 82. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2024-2029) & (K MT)
Table 83. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Volume by Country (2024-2029)
Table 84. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2024-2029) & (US$ Million)
Table 85. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Value by Country (2024-2029)
Table 86. Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Region (2018-2024) & (K MT)
Table 87. Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Volume by Region (2018-2024)
Table 88. Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Region (2018-2024) & (US$ Million)
Table 89. Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Value by Region (2018-2024)
Table 90. Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Region (2024-2029) & (K MT)
Table 91. Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Volume by Region (2024-2029)
Table 92. Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Region (2024-2029) & (US$ Million)
Table 93. Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Value by Region (2024-2029)
Table 94. Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2018-2024) & (K MT)
Table 95. Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Volume by Country (2018-2024)
Table 96. Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2018-2024) & (US$ Million)
Table 97. Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Value by Country (2018-2024)
Table 98. Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2024-2029) & (K MT)
Table 99. Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Volume by Country (2024-2029)
Table 100. Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2024-2029) & (US$ Million)
Table 101. Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Value by Country (2024-2029)
Table 102. Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2018-2024) & (K MT)
Table 103. Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Volume by Country (2018-2024)
Table 104. Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2018-2024) & (US$ Million)
Table 105. Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Value by Country (2018-2024)
Table 106. Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2024-2029) & (K MT)
Table 107. Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Volume by Country (2024-2029)
Table 108. Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2024-2029) & (US$ Million)
Table 109. Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Value by Country (2024-2029)
Table 110. AstraZeneca Company Information
Table 111. AstraZeneca Introduction and Business Overview
Table 112. AstraZeneca Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 113. AstraZeneca Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product
Table 114. AstraZeneca Recent Development
Table 115. Boehringer Company Information
Table 116. Boehringer Introduction and Business Overview
Table 117. Boehringer Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 118. Boehringer Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product
Table 119. Boehringer Recent Development
Table 120. Eli Lilly Company Information
Table 121. Eli Lilly Introduction and Business Overview
Table 122. Eli Lilly Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 123. Eli Lilly Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product
Table 124. Eli Lilly Recent Development
Table 125. Merck Company Information
Table 126. Merck Introduction and Business Overview
Table 127. Merck Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 128. Merck Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product
Table 129. Merck Recent Development
Table 130. Mitsubishi Tanabe Pharma Company Information
Table 131. Mitsubishi Tanabe Pharma Introduction and Business Overview
Table 132. Mitsubishi Tanabe Pharma Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 133. Mitsubishi Tanabe Pharma Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product
Table 134. Mitsubishi Tanabe Pharma Recent Development
Table 135. Novartis Company Information
Table 136. Novartis Introduction and Business Overview
Table 137. Novartis Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 138. Novartis Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product
Table 139. Novartis Recent Development
Table 140. Takeda Company Information
Table 141. Takeda Introduction and Business Overview
Table 142. Takeda Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 143. Takeda Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product
Table 144. Takeda Recent Development
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Trends
Table 148. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Drivers
Table 149. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Challenges
Table 150. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Restraints
Table 151. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Distributors List
Table 152. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Downstream Customers
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Picture
Figure 2. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Status and Outlook (2018-2029) & (K MT)
Figure 5. Product Picture of Sitagliptin
Figure 6. Global Sitagliptin Sales YoY Growth (2018-2029) & (K MT)
Figure 7. Product Picture of Vildagliptin
Figure 8. Global Vildagliptin Sales YoY Growth (2018-2029) & (K MT)
Figure 9. Product Picture of Saxagliptin
Figure 10. Global Saxagliptin Sales YoY Growth (2018-2029) & (K MT)
Figure 11. Product Picture of Linagliptin
Figure 12. Global Linagliptin Sales YoY Growth (2018-2029) & (K MT)
Figure 13. Product Picture of Others
Figure 14. Global Others Sales YoY Growth (2018-2029) & (K MT)
Figure 15. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2018-2029) & (US$ Million)
Figure 16. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Type in 2022 & 2029
Figure 17. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Volume by Type in 2022
Figure 18. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Value by Type in 2022
Figure 19. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Volume by Type in 2022
Figure 20. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Value by Type in 2022
Figure 23. Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue in 2022
Figure 29. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Hospital Pharmacies
Figure 31. Global Hospital Pharmacies Sales YoY Growth (2018-2029) & (K MT)
Figure 32. Product Picture of Retail Pharmacies
Figure 33. Global Retail Pharmacies Sales YoY Growth (2018-2029) & (K MT)
Figure 34. Product Picture of Online Pharmacies
Figure 35. Global Online Pharmacies Sales YoY Growth (2018-2029) & (K MT)
Figure 36. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2018-2029) & (US$ Million)
Figure 37. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Application in 2022 & 2029
Figure 38. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Volume by Application in 2022
Figure 39. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Value by Application in 2022
Figure 40. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Volume by Application in 2022
Figure 41. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Value by Application in 2022
Figure 44. Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Manufacturing Cost Structure
Figure 49. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries